Management of Acute Agitation in Geriatric Patients
For acute agitation in geriatric patients, low-dose haloperidol (0.5-1 mg orally or subcutaneously) is the first-line medication when non-pharmacological interventions have failed and the patient is severely agitated with risk of harm to self or others. 1
First Steps: Non-Pharmacological Approaches
Always address reversible causes of agitation before considering medication:
- Explore patient's concerns and anxieties 1
- Ensure effective communication and orientation (explain where they are, who you are) 1
- Provide adequate lighting 1
- Treat reversible causes such as hypoxia, urinary retention, constipation, pain, or infection (especially UTI and pneumonia) 1
Pharmacological Management Algorithm
1. For Severe Agitation with Delirium (Patient Able to Swallow)
First-line: Haloperidol 0.5-1 mg orally at night and every 2 hours as required 1
Second-line options (if haloperidol ineffective or contraindicated):
2. For Severe Agitation with Delirium (Patient Unable to Swallow)
First-line: Haloperidol 0.5-1 mg subcutaneously as required 1
- Consider subcutaneous infusion of 2.5-10 mg over 24 hours if needed frequently 1
Alternative: Levomepromazine 6.25-12.5 mg subcutaneously (for elderly patients) 1
- Maintain with subcutaneous infusion of 50-200 mg over 24 hours 1
3. For Anxiety or Agitation Without Delirium (Patient Able to Swallow)
- If benzodiazepine indicated: Lorazepam 0.25-0.5 mg orally (maximum 2 mg in 24 hours) 1
4. For Anxiety or Agitation Without Delirium (Patient Unable to Swallow)
- If benzodiazepine indicated: Midazolam 2.5-5 mg subcutaneously every 2-4 hours 1
- Reduce dose to 5 mg over 24 hours if eGFR <30 mL/minute 1
Important Considerations and Caveats
Antipsychotics should only be used at the lowest effective dose for the shortest possible duration 1
Do NOT use antipsychotics or benzodiazepines for hypoactive delirium without agitation 1
Benzodiazepine risks in elderly patients:
Haloperidol dosing caution: Higher than recommended doses (>1 mg/24h) significantly increase risk of sedation without improving effectiveness 4
Atypical antipsychotics considerations:
Physical restraints should be minimized whenever possible 1
Medication Selection Based on Comorbidities
For patients with Parkinson's disease: Quetiapine preferred 2
For patients with diabetes, dyslipidemia, or obesity: Avoid clozapine, olanzapine, and low/mid-potency conventional antipsychotics 2
For patients with QTc prolongation or heart failure: Avoid clozapine, ziprasidone, and conventional antipsychotics 2
For patients with cognitive impairment: Risperidone preferred, with quetiapine as second-line 2
Remember that the goal of treatment is to manage acute agitation while minimizing adverse effects, particularly in this vulnerable population. Always use the lowest effective dose for the shortest duration necessary.